尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the detailed record of transactions filed by Chaubey Alka. Officer active across 1 company, notably Bionano Genomics, Inc.. Aggregated, 10 disclosures have been logged. History available since 15 February 2023. The latest transaction was filed on 3 June 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 条申报中的 10 条
Chaubey Alka is a declarant linked to Bionano Genomics, Inc., where the listed role is CHIEF MEDICAL OFFICER. She has 10 filings in total, and within the recent sampled filings the most common transaction nature is Retenue fiscale, with buy and sell amounts of €0 over the period from 2023-02-17 to 2026-06-03.